Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Biology

Background:

• Phosphorylation of RNA polymerase II's largest subunit C-terminal domain (CTD) is critical for mRNA metabolism.
• Conventional biochemical methods struggle to identify CTD phosphorylation sites due to its repetitive nature.
• Specialized monoclonal antibodies offer a solution for distinguishing phosphorylated RNAP II isoforms.

Purpose of the Study:

• To review the utility of monoclonal antibodies in monitoring RNA polymerase II (RNAP II) phosphorylation in vivo.
• To explore the role of CTD phosphorylation patterns in gene transcription and RNA processing factor recruitment.
• To discuss the impact of physiological contexts on global RNAP II phosphorylation.

Main Methods:

• Utilizing a panel of monoclonal antibodies specific to phosphorylated RNAP II CTD.
• Employing immunofluorescence, chromatin immunoprecipitation, and immunoblotting for in vivo analysis.
• Reviewing existing studies that used these antibody tools.

Main Results:

• Monoclonal antibodies successfully monitor RNAP II phosphorylation changes in vivo.
• CTD phosphorylation patterns dynamically change during RNAP II gene progression, influencing RNA processing.
• The H5 antibody is a recognized marker for actively transcribing RNAP II molecules.

Conclusions:

• Monoclonal antibodies are invaluable tools for studying RNAP II CTD phosphorylation.
• CTD phosphorylation dynamics are integral to transcription and RNA processing.
• RNAP II phosphorylation is modulated by cellular states like stress and development.